Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
60 Cards in this Set
- Front
- Back
A malignant ds of blood-forming organs; 8% of cancers
|
LEUKEMIA
|
|
Most common leukemia in children and young adults
|
LYMPHATIC LEUKEMIA 80%
|
|
Risk factors to leukemia
|
BENZENE, ALKYLATING AGENTS, DOWN SYNDROME, HTLV-1
|
|
Pathophysiology of leukemia
|
uncontrolled leukocyte production, undifferentiated leuks (blasts) with infiltration of blood forming organs
|
|
Classification of leukemias
|
morphological characteristics thru staining of blast cells
|
|
50% of marrow cells are immature
|
ACUTE LEUKEMIA
|
|
Two forms of acute leukemia
|
LYMPHOCYTIC AND NONLYMPHOCYTIC
|
|
A reduction in all cellular components of the blood
|
PANCYTOPENIA
|
|
Most common in children (11 yrs)
|
all
|
|
Common in adults (67 yrs)
|
aml
|
|
Involves rapid accumulation of hematopoietic stem cells
|
AML
|
|
HX involves military and powerplants, radiation, meds
|
AML
|
|
s/s sudden hi-fever, bruising, petecheae, bleeding, blurred vision, DIC
|
AML
|
|
defect in hematopoietic stem cells
|
AML
|
|
drugs for AML
|
IDARUBICIN, NOVANTRONE, CYTOSAR
|
|
complication of radiation in AML patients
|
TUMOR LYSIS SYNDROME
|
|
treatment of AML
|
drugs, BMT, PRBC, RADIATION, CHEMO
|
|
Hallmark sign of AML
|
neutropenia
|
|
Characterized by uncontrollable spread of small B lymphocytes
|
CLL
|
|
Most common in US leukemia
|
CLL
|
|
Least malignant form of leukemia; takes as long as 15 yrs
|
CLL
|
|
Characterized by abnormal overgrowth of myeloblasts
|
CML
|
|
Mutating myeloid stem cells
|
CML
|
|
Has two phases: insidious chronic phase and acute (blast) phase
|
CML
|
|
Drugs to treat CML
|
IMATINIB, INTERFERON
|
|
Drugs to treat CLL
|
fludarabine, CHLORAMBUCIL, RITUXIMAB
|
|
Enlarged lymph nodes, anemia, ITP, hemolytic anemia, ANERGY, herpes
|
CLL
|
|
Drugs to treat ALL
|
IMATINIB, CAMPATH
|
|
Presence of philly or chromosome 22
|
CML
|
|
Results from abnormal production of granulocytic cells
|
CML
|
|
Presence of REED-Sternberg cells
|
HODGKIN’S LYMPHOMA
|
|
Suspects EPSTEIN-Barr virus, MONO, JEWS
|
HODGKIN’s lymphoma
|
|
Painless progressive enlargement of LN, with increased lymphocytes, histiocytes and eosinophils and REED Sternberg giant cells
|
HODGKIN’S
|
|
Non-productive cough with mediastinal mass in 50% of patients
|
HODGKINS
|
|
Presence of B-symptoms
|
HODGKINS
|
|
Treatment for hodgkin’s
|
radiation/chemo, combo
|
|
Presence of neoplastic growth of lymphoid tissue
|
NON-HODGKIN’S
|
|
Random proliferation of lymphocytes originating from lymphoid cells
|
non-HODGKIN’S
|
|
7X MORE COMMON than hodgkin’s; 60X ON aids pts
|
non-HODGKINS
|
|
6th common cause of cancer/deaths
|
non-HODGKINS
|
|
What are B symptoms
|
fever, night sweats, weight loss > 10%
|
|
Abnormal mass of tissue that harms host organism
|
NEOPLASM
|
|
A stem cell disorder within the bone marrow
|
A stem cell disorder within the bone marrow
|
|
Caused by increased platelet production
|
SECONDARY THROMBOCYTOPENIA
|
|
Can result from decreased production, increased destruction/consumption of platelets
|
THROMBOCYTOPENIA
|
|
Phagocytic engulfement of platelets due to
|
ITP
|
|
Caused by genetic defect that results in deficient or defective factor VIII
|
Hemophilia A-eight
|
|
Caused by genetic defect that results in deficient or defective factor IX
|
Hemophilia B-nine
|
|
A defect in a factor that necessitates adhesion of factor VIII
|
Von Willebrand’s Ds
|
|
Medical goals for hemophilia
|
STOP BLEEDING, RAISE AHF by infusion of VIII and IX (Eight/nine)
|
|
Therapies for blood disorders
|
SPLENECTOMY, APHERESIS, PHLEBOTOMY, TRANSFUSIONS
|
|
Transfusion complications
|
fever, hemolysis, allergic rxn, circulatory overload, infection, lung injury, delayed hemolytic rxn, iron toxicity, long-term complications
|
|
Life threatening disorder in which bleeding and coagulation occur simultaneously
|
DIC
|
|
Disorder with presence of microclots in capillaries, micro-infarcts, FDPs
|
DIC
|
|
Occurs as a response to shock, trauma, cirrhosis, conditions releasing factor III such as fat emboli, snake bits, abruption placenta, IUFD
|
DIC
|
|
Can occur with women who developed PIH
|
DIC
|
|
Lab values for DIC
|
PLATELETS <100,000 , FIBRINOGEN <150, PTT >15 SECS, POSITIVE D-DIMERS
|
|
How to correct DIC
|
PRBCs, FFP, Cryoprecipitate, Platelets, Heparin, Bleeding control
|
|
When to use heparin (low dose 300-500) in DIC
|
acute renal failure and/or skin ischemia
|
|
DIC is marked by :
|
CLOTTING AND HEMMORHAGE (BLEEDING)
|